Comments

Protagonist Therapeutics Stock News

PTGXNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$93.37
-1.42-1.50%
Last update: Dec 16, 10:28 AM
Overview

News

EarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report

Latest Protagonist Therapeutics Stock News | NASDAQ:PTGX | Benzinga

Get the latest news on Protagonist Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Protagonist Therapeutics performance

People Also Watch

Immunovant Inc
NASDAQ:IMVT
$26.16
0.62%
Legend Biotech Corp
NASDAQ:LEGN
$21.92
-0.41%
Cogent Biosciences Inc
NASDAQ:COGT
$40.41
0.41%
Celcuity Inc
NASDAQ:CELC
$100.52
-1.63%
Alkermes PLC
NASDAQ:ALKS
$27.90
-0.96%
PTC Therapeutics Inc
NASDAQ:PTCT
$75.00
-1.64%
Vaxcyte Inc
NASDAQ:PCVX
$44.04
-0.68%
TG Therapeutics Inc
NASDAQ:TGTX
$31.03
-1.21%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved